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Objective To study the etiology of clinically diagnosed community-acquired pneumonia
(CAP) in antibiotically naive patients attending a primary care center and treated at their
homes.
Methods A three-year prospective study was carried out, and 177 patients presenting
with clinical signs of CAP were included. All patients had chest X-rays after inclusion,
and 82 (46%) showed infiltrates. Nasopharyngeal swab culture was performed on all
patients, and 51% produced a representative sputum sample. Paired sera were obtained
from 176 patients.
Results Among the 82 patients with radiographically proven CAP, Streptococcus pneu-
moniae was detected in 26 patients (32%), Haemophilus influenzae in 23 (28%), Mycoplasma
pneumoniae in 15 (18%), and Chlamydia pneumoniae in four (5%). Serologic evidence of a
viral infection was found in 13 patients (16%). Among the 95 patients without infiltrates,
S. pneumoniae was found in 21 (22%), H. influenzae in 14 (15%), M. pneumoniae in two (2%),
and C. pneumoniae in five (5%). Viral infection was detected in 19 (20%) of these 95
patients.
Conclusion In primary care in Sweden, the initial antibiotic treatment in any patient with
pneumonia should be effective against S. pneumonia and H. influenzae. In addition, M.
pneumoniae should be targeted during recurrent epidemics. C. pneumoniae, and especially
Legionella, seem to be uncommon in primary care.
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I N T R O D U C T I O N
Community-acquired pneumonia (CAP) is a major
cause of morbidity in the community, and is one of
the greatest burdens on the health service. Most of
the patients with these infections are treated in
primary care, and in only about 15% of the cases is
hospital admission required [1]. Many attempts
have been made to establish the etiology of CAP in
hospitalized patients. In these studies, Streptococ-
cus pneumoniae has been shown to be the dominant
agent. However, the etiology of CAP in primary
care may be different, and guidelines for treatment
based on inpatients might not be relevant to out-
patient therapy. Only a few studies have been
focused on patients with pneumonia in primary
care. In one of the largest, conducted in the UK in
1984–85, S. pneumoniae was found to be the most
common etiologic agent (36%), followed by Hae-
mophilus influenzae (10%) and Mycoplasma pneumo-
niae (1%) [2]. The etiologic diagnoses in the
majority of these cases were based on the finding
of pneumococcal polysaccharide antigen in the
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sputum. In another frequently cited study, M.
pneumoniae was found to be the most common
causative organism (37%) among 54 young out-
patients attending or referred to a department of
infectious diseases in Sweden [3]. The etiologic
diagnoses in that study were based on serologic
evidence.
We describe here the findings in a three-year
prospective study in a Swedish population, under-
taken to investigate the etiology of CAP in anti-
biotically naive patients attending a primary care
center and treated in their homes.
P A T I E N T S A N D M E T H O D S
Patients
The catchment area of the Varberga Primary Care
Health Center (VHC), situated in a medium-sized
town (O¨rebro, 120 000 inhabitants) in central
Sweden, has a mixed population (urban, sub-
urban, and rural) of about 8000. The present
study covered the period from 1 November
1995 to 31 October 1998, during which time four
general practitioners and one new trainee physi-
cian each year were on duty and assisted in the
study. The study was carried out in regular work-
ing hours in the daytime from Monday to Friday,
and not at weekends or evenings/nights. For
ethical reasons, patients under ten years of age
were excluded. A few patients (<5) with severe
illness in need of hospital treatment were also
excluded, as well as patients living in nursing
homes, as the aim was to study patients treated at
home. In addition, four patients who had
received antibiotic treatment during the last
month were excluded.
Patients given a diagnosis of CAP on clinical
grounds entered the study at the first consultation
with the doctor, before the results of the X-ray,
blood tests or microbiological examinations were
available. This was done to simulate and corre-
spond to daily clinical practice, as the diagnosis of
CAP in primary care is often based on clinical
findings [4,5].
For the purpose of the study, the following
inclusion criteria were established:
1. fever (>38 8C) and cough for less than one
week, or
2. long-standing (one to four weeks) dry cough
with or without fever.
In addition, at least one of the following signs or
symptoms had to be present: (1) lateral chest pain;
(2) crackles or wheezes on auscultation; or (3)
appearance of illness.
Examinations
Blood samples for serologic analysis, and naso-
pharyngeal swabs and sputum samples for bacter-
ial isolation were obtained at the first (emergency)
visit. All samples were kept cold until transported
to the microbiological department, and were pro-
cessed on the day of collection. If spontaneously
expectorated sputum was not available, the pati-
ents were asked to inhale hypertonic saline (3%),
which often resulted in a sputum specimen. All
patients were chest X-rayed on the day of the first
visit, after inclusion in the study.
The patients were asked to return after three to
four weeks for a follow-up visit, including a clin-
ical examination and blood sampling for analysis
of convalescent serum.
Blood cultures were not performed.
Bacteriologic procedures
Nasopharyngeal swabs were cultured on hematin
agar (horse blood 8.5%) and bovine blood agar
(10%) with gentian violet (3 mg/L), with incuba-
tion at 37 8C in moist air with 5% CO2. The cultures
were inspected after one and two days, and poten-
tially pathogenic bacteria were subcultured and
identified by standard methods.
Sputum culture was performed in a semiquan-
titative manner [6]. The sputum samples were
homogenized with an equal volume of Mucolyze
(PRO-LAB Inc., Ontario, Canada), shaken on a
vortex mixer for 5 min, and then incubated at
room temperature for another 15 min. Smears
were prepared, Gram-stained and examined
microscopically to determine the leukocyte/squa-
mous epithelial cell ratio. Specimens with >5 leu-
kocytes per squamous cell were regarded as
purulent, and those with 1–5 leukocytes per squa-
mous cell as acceptable. A sample of the homo-
genized sputum was diluted 1 : 100 with nutrient
broth (Oxoid Ltd., Basingstoke, UK). Portions
(1 mL) of this dilution were cultured on hematin
agar with a 50-mg oleandomycin disk, and on
bovine blood agar with gentian violet provided
with a paper disk containing 6 mg of optochin, and
incubated in moist air with 5% CO2. With this
dilution, one colony represents 2  105 CFU/mL,
which thus was the smallest number of bacteria
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taken into account. The cultures were inspected
after one and two days, and potentially pathogenic
bacteria were subcultured and identified by stan-
dard methods. No microscopic evaluation of the
bacterial morphology was performed.
Serologic procedures
Acute (day 1) and convalescent (three to four
weeks later) sera were submitted to serologic test-
ing. Complement-fixation tests were performed
to analyze the sera for M. pneumoniae, influenza
A and B viruses, adenovirus, and respiratory syn-
cytial (RS) virus. A four-fold rise in titer or a titer
1/160 was regarded as positive in all these ana-
lyses. Chlamydia-specific analyses (C. pneumoniae,
C. psittaci, and C. trachomatis) were performed with
a microimmunofluorescence technique (MIF) for IgG
and IgM. A four-fold rise in IgG titer or an IgM
titer 1/16 was regarded as a positive finding.
Legionella pneumophila serogroup 1–6, L. micda-
dei, L. bozemanii and L. long-beachae 1 þ 2 analyses
were carried out with an immunofluorescence
technique (Dr I. Kallings, Swedish Institute for
Infectious Diseases Control, Stockholm). A four-
fold rise in IgG titer or a titer>1/128 was regarded
as a positive finding. In all runs, sera with known
antibody titers were used as positive and negative
controls for each microorganism.
Measurement of serum antibodies against
Streptococcus pneumoniae
An indirect ELISA was established, in principle
as described earlier, for detection of serum IgG
antibodies [7] (Professor R. Mo¨llby, Karolinska
Institutet, Stockholm, Sweden). The proteinaceous
toxin pneumolysin was highly purified from a
strain of S. pneumoniae serotype 14 [8] and cova-
lently linked to microtiter plates (Covalink NH
plates, Nunc Intermed, Roskilde, Denmark); the
outer-surface polysaccharide C was highly puri-
fied from strain CSR-SCS-2 clone 1, essentially as
described by Holmberg et al. [6], and coated on
polystyrene microplates (Nunc Intermed), accord-
ing to standard procedures, in duplicate wells. For
pneumolysin, antibody levels were expressed as
relative ELISA titers, i.e. the absorbance value
multiplied by the dilution (1/1000), and for poly-
saccharide C they were expressed as units derived
from the relationship between the patient sample
(dilution 1/4000) and the standard curve of a
reference serum (UNREF [9]). Doubling of the
antibody level, between acute and convalescent
serum, against at least one of the two antigens was
considered to be a positive serologic result for the
patient in question.
R E S U L T S
During the three-year study period, 180 patients
fulfilled the inclusion criteria. Three patients
declined to participate. Thus, 177 entered the
study, of whom 112 (63%) were women. Of these
patients, 134 (76%) had an acute infection with
cough and fever (criterion 1), and 43 (24%) were
suffering from more long-standing symptoms
(criterion 2). Nine of the included patients (5%)
had lateral chest pain as the only additional symp-
tom (sign/symptom A), 46 (26%) had signs on
auscultation (sign/symptom B), and 32 (18%) were
‘apparently ill’ (sign/symptom C). The other 90
patients included (51%) had various combinations
of signs or symptoms A, B, and C. The mean age of
the 177 patients was 51 years (range 10–84 years),
and 50 (28%) were smokers. Eight patients were
below 18 years of age. Fifty-one (29%) patients had
underlying diseases (Table 1). There were no
deaths in the study group during the three-year
period.
All 177 patients were chest X-rayed after inclu-
sion, and 82 (46%) showed infiltrates indicating
acute pneumonia. Nasopharyngeal swab culture
was performed in all 177 patients, and 125 patients
(70%) were able to produce a sputum sample.
Sixty-one samples were found to be purulent,
and 30 were acceptable. The 34 non-acceptable
specimens were discarded. An acute serum sam-
ple was collected from all patients, and 176 of
the patients returned for clinical follow-up, when
convalescent sera were obtained.
Table 1 Underlying diseases in 177 patients with clinically
diagnosed community-acquired pneumonia in primary
care in O¨rebro, Sweden
No. %
Asthma 17 10
COPD 13 7
Diabetes mellitus 8 5
Cardiovascular disease 8 5
Neoplasma 5 3
Alcoholic abuse 3 2
aOf these, four were pulmonary malignancies.
COPD, chronic obstructive pulmonary disease.
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Patients with infiltrates
S. pneumoniae was detected in 26 (32%) of the 82
patients with infiltrates on chest X-ray (Table 2). In
13 patients, this pathogen was found in a sputum
specimen, and in another eight patients it was
found only in the nasopharynx. Four patients with
a nasopharyngeal finding of S. pneumoniae were
also seropositive for this pathogen. In five patients,
there was serologic evidence of pneumococcal
infection without any finding of S. pneumoniae in
the sputum or nasopharynx.
H. influenzae was found in 23 (28%) of the 82 pati-
ents. This pathogen was identified in 19 sputum
samples, and additionally in four nasopharyngeal
cultures. In ten of the 14 patients in whom H.
influenzae was isolated in the nasopharynx, the same
pathogen was also identified in sputum specimens.
Serologic indication of a mycoplasma infection
was found in 15 (18%) of the 82 patients. In four of
these patients, S. pneumoniae or H. influenzae was
also isolated from a sputum specimen.
Serologic evidence of C. pneumoniae was
obtained in four (5%) of the 82 patients. Two of
these four patients showed a four-fold rise in the
IgG antibody titer, and in another two patients
IgM was found in the acute sera. Two of the four
patients were also infected with pneumococci, and
another one of them with H. influenzae.
Influenza infection was detected in 12 of the 82
patients, influenza A in eight, and influenza B in
four.
Patients without infiltrates
Indications of a pneumococcal infection were
found in 21 (22%) of the 95 patients without infil-
trates on chest X-ray (Table 3). In three of the five
patients in whom S. pneumoniae was isolated from
the nasopharynx, the same pathogen was also
identified in the sputum.
H. influenzae was demonstrated in 14 (15%) of
the 95 patients. In nine of the ten patients in whom
H. influenzae was recovered from the nasopharynx,
the same pathogen was also identified in sputum
specimens.
C. pneumoniae was found in five (5%) of the 95
patients, four with positive IgM and one with a
four-fold rise in antibody titer in the serologic test.
One of these patients also had S. pneumoniae and H.
influenzae in a sputum specimen.
M. pneumoniae was detected in two (2%) of the
95 patients. Both showed a four-fold rise in the
antibody titer test. One of the patients also dis-
played serologic evidence of a pneumococcal
infection.
Fifteen patients were infected with influenza: 12
with influenza A, and three with influenza B.
Presumed etiology in patients with and without
infiltrates on chest X-ray
The presumed etiologies in all of the 177 patients
with and without infiltrates on X-ray are shown
in Table 4. These figures are based on serologic
Table 2 Microorganisms detected in 82 patients with clinically diagnosed community-acquired pneumonia showing
infiltrates on chest X-ray
Pathogen Serology
Sputum
Nasopharyngeal
swab culture
Total number of
patientsPurulenta Acceptableb
With
positive sputum Npconly
Streptococcus pneumoniae 11 9 4 11 8 26
Haemophilus influenzae 15 4 10 4 23
Mycoplasma pneumoniae 15 15
Chlamydia pneumoniae 4 4
Chlamydia psittaci 1 1
Influenza A þ Bd 12 12
Moraxella catarrhalis 2 2 2 4
Pseudomonas aeruginosa 1 1
Staphylococcus aureus 6 6
RS virus 1 1
a>5 leukocytes/squamous epithelial cell.
b1–5 leukocytes/squamous epithelial cell.
cNasopharyngeal swab culture.
dInfluenza A eight, influenza B four.
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findings, on isolation of a potential pathogen
(2  105 CFU/mL) in acceptable or purulent
sputum, and on the presence of S. pneumoniae
and H. influenzae in a nasopharyngeal culture.
Pathogenic microorganisms were detected in 111
(63%) of the 177 patients. Among these, a single
pathogen was found in 76 patients (43%), two
pathogens in 32 patients (18%), and three patho-
gens in three patients (2%).
D I S C U S S I O N
In primary care, CAP is a clinical diagnosis, and in
most cases a radiologic examination is not avail-
able. In various studies of patients arousing clin-
ical suspicion of pneumonia, the frequency of
positive X-ray findings contributing to the clinical
diagnosis of CAP in patients in primary care has
ranged from 12% [10] to 84% [11]. A positive chest
Table 3 Microorganisms detected in 95 patients with clinically diagnosed community-acquired pneumonia without
infiltrates on chest X-ray
Pathogen Serology
Sputum
Nasopharyngeal
swab culture
Total number of
patientsPurulenta Acceptableb
With
positive sputum
Npc
only
Streptococcus pneumoniae 13 5 2 3 2 21
Haemophilus influenzae 8 5 9 1 14
Mycoplasma pneumoniae 2 2
Chlamydia pneumoniae 5 5
Influenza A þ Bd 15 15
Moraxella catarrhalis 1 2 2 8 11
Staphylococcus aureus 3 3
Neisseria meningitidis group B 1 1 1
Adenovirus 3 3
RS virus 2 2
a>5 leukocytes/squamous epithelial cell.
b1–5 leukocytes/squamous epithelial cell.
cNasopharyngeal swab culture.
dInfluenza A 12, influenza B three.
Table 4 Presumed etiology of clinically dignosed community-acquired pneumonia in patients attending primary care, with
(n ¼ 82) and without (n ¼ 95) infiltrations on X-ray
Etiology
With
infiltrate n (%)
Without
infiltrate n (%)
All
patients n (%)
Streptococcus pneumoniae 12 (15) 11 (11) 23 (13)
S. pneumoniae þ Haemophilus influenzae 3 (4) 3 (3) 6 (3)
S. pneumoniae þ Mycoplasma pneumoniae 3 (4) 1 (1) 4 (2)
S. pneumoniae þ Chlamydia pneumoniae 2 (2) 0 2 (1)
S. pneumoniae þ H. influenzae þ M. pneumoniae 1 (1) 0 1 (0,5)
S. pneumoniae þ H. influenzae þ C. pneumoniae 0 1 (1) 1 (0,5)
S. pneumoniae þ various (Infl. A 6, Infl. B 3, Adeno 1) 5 (6) 5 (5) 10 (6)
Haemophilus influenzae 12 (15) 5 (5) 17 (10)
H. influenzae þ M. pneumoniae 1 (1) 0 1 (0,5)
H. influenzae þ C. pneumoniae 1 (1) 0 1 (0,5)
H. influenzae þ various (Infl. A 4, Infl. B 2, Moraxella 2, RS 2, Adeno 1) 5 (6) 5 (5) 10 (6)
Mycoplasma pneumoniae 10 (12) 1 (1) 11 (6)
Chlamydia pneumoniae 1 (1) 4 (4) 5 (3)
Influenza A 4 (5) 6 (6) 10 (6)
Moraxella catarrhalis 1 (1) 2 (2) 3 (2)
Various (C. psittaci 1, N. meningitidis group B 1, Adeno 1, RS 1, Infl. B 2) 1 (1) 5 (5) 6 (3)
Legionella species 0 0 0
Unknown 20 (24) 47 (49) 66 (37)
Total 82 95 177
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X-ray is often considered to be obligatory in the
diagnosis of CAP. However, patients with relevant
symptoms and signs but a negative X-ray might
also be suffering from a parenchymal lung infec-
tion. In a newly published study on 47 patients
with clinical signs and symptoms of CAP, high-
resolution computed tomography (HRCT) identi-
fied all 18 patients as positive on chest X-ray, as
well as eight additional cases [12]. Such findings
imply that a general requirement for a new infil-
trate on chest X-ray for a diagnosis of pneumonia
could be questioned. From a clinical point of view,
all of our patients were considered by the general
practitioner to be suffering from CAP. However, as
the group with infiltrates and the group without
were found to differ etiologically, the results for
each group are reported separately in Tables 2–4.
The present study indicates that the most com-
mon etiology of CAP seen in primary care in
Sweden is S. pneumoniae (32%), followed by H.
influenzae (28%) and M. pneumoniae (18%). In our
group without infiltrates on X-ray, S. pneumoniae
was found to a lesser extent (22%) but was still the
most common organism, here again followed by
H. influenzae (14%), C. pneumoniae (5%), and M.
pneumoniae (2%). These results are in partial agree-
ment with those from a study by Woodhead et al
[2], but differ from those of other studies on CAP
outpatients [3,5,11,13] in the finding of a high
proportion of patients with H. influenzae infection.
Smoking often leads to chronic bronchitis and an
increased frequency of H. influenzae infections. The
number of smokers in our study (28%) was about
the same as in the UK study [2]. Possibly, an
increased number of smokers among women
may account for the difference in the etiologic
spectrum of CAP in Sweden.
Obviously, there is a risk of contamination in the
oropharynx when sputum is expectorated. By dis-
carding sputum samples that were not represen-
tative, and not taking into account pathogens
found at levels of <2  105 CFU/mL, this poten-
tial problem was at least diminished. It has been
shown that patients with bacteremic pneumococ-
cal pneumonia often harbor an identical pneumo-
coccal serotype in the nasopharynx, and therefore
the isolation of S. pneumoniae in a nasopharyngeal
specimen is believed to point to these pathogens as
possible etiologic factors in Sweden [14,15]. Many
of our patients with S. pneumoniae or H. influenzae
in the nasopharynx also had the same pathogen in
their sputum specimen, supporting this view. A
recent study in Sweden has also demonstrated a
very low carrier rate of these two pathogens in
healthy adults [16].
An advantage of the present study is the rela-
tively long observation time (three years), which
reduced the influence of seasonal and epidemio-
logic variations on the etiologic findings. During
the second year, for example (September 1996 to
September 1997), only one case of M. pneumoniae
occurred. In one-year studies comprising mainly
outpatients, M. pneumonia has been detected with a
frequency ranging from 0.5% [2] to 23% [17].
In contrast to the high frequency of Legionella
found in studies in the Mediterranean countries
(Spain, Italy) [18–20], this pathogen was not
detected as the cause of any infection in the present
study. During the three-year period, one known
case of L. pneumophila infection occurred in the
catchment area of VHC, but this patient was
referred to and treated in the nearby hospital.
The same low frequency of Legionella among out-
patients has been reported from the UK [2,13],
Canada [17], and Finland [21].
The diagnostic problems with C. pneumoniae
infections are well known. As a criterion, we
required a four-fold rise in IgG titer or an IgM
titer of 1/16 with MIF. This meant that a stable
high titer of 1/512 or 1/1028 (which was found in
39 (22%) of our 177 patients) was not regarded as
indicative of such an infection, which is an impor-
tant reason for the rather low frequency found (9/
177; 5%). In three of these nine patients with C.
pneumoniae infection, there was evidence of an
additional pneumococcal infection, and in another
two patients H. influenzae was found, indicating
that C. pneumoniae may predispose to infection
with other pathogens, especially S. pneumoniae
[22].
The significance and frequency of mixed infec-
tions in CAP has been increasingly reported. The
number of mixed infections observed in the pre-
sent study was quite high. The well known com-
bination of S. pneumoniae and H. influenzae was
found in only six patients, and a combination of
two or more pathogens (bacterial or viral) was
present in a further 29 patients. Thus, altogether,
20% of the patients seemed to have had mixed
infections.
A totally different etiologic result was reported
from a Swedish investigation of 54 outpatients
attending or referred to a hospital outpatient clinic
during a three-year period [3]. That study popula-
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tion represented a selection of fairly young people
(median age<31 years), partly referred because of
failure of antibiotic (b-lactam) therapy, and, not
surprisingly, the most frequent pathogen was M.
pneumoniae (37%), followed by S. pneumoniae (9%).
In a recent report from Finland on a population-
based study from 1981 to 1982, yet another differ-
ent pattern was described. The etiologic diagnoses
were based on serologic procedures (paired serum)
or antigen detection in urine from 169 outpatients
with X-ray-confirmed CAP, and the most frequent
pathogen was S. pneumoniae (22%), followed by M.
pneumoniae (8%), C. pneumoniae (5%), viruses (5%),
and H. influenzae (2%) [21]. Their results are in
agreement with our serologic findings.
A study in the UK, published in 1987, comprised
236 patients with acute respiratory tract infection,
which on clinical grounds was diagnosed by the
responsible general practitioner as CAP [2]. Chest-
X-ray was performed in almost all patients (of
whom 39% showed infiltrates), sputum culture
in 70% (no quality assessment), and serology in
97%. The most frequent pathogen was S. pneumo-
niae (36%), and this was mostly detected by a
pneumococcal capsular antigen test on sputum.
H. influenzae was the second most frequent patho-
gen, and was found in 24 patients (10%), in 23 of
whom it was identified in sputum cultures; thus,
in agreement with our study, H. influenzae was
actually the most frequent pathogen isolated from
sputum. In the UK study, blood culture had a low
diagnostic yield (one patient each with S. pneumo-
niae and H. influenzae), which gave us reason to
exclude blood culture in our study.
Through an oversight in the present study, no
sputum specimens were frozen in the laboratory,
and thus no pneumococcal antigen tests or PCR for
C. pneumoniae and M. pneumoniae could be per-
formed afterwards. This is a shortcoming of our
study, which in our view is balanced by the high
frequency of paired sera (99%) and the large num-
ber of cultured sputum specimens (purulent or
acceptable sputum from 51% of the patients).
In our opinion, examination of both sputum and
nasopharyngeal specimens, together with serolo-
gic tests, leads to a more complete and probably a
more true picture of the etiologic panorama of
CAP in primary care.
In view of the frequency of S. pneumoniae and H.
influenzae in the present study, the initial antibiotic
treatment in any patient with pneumonia should
always be effective against S. pneumoniae and H.
influenzae. In addition, M. pneumoniae should be
targeted during recurrent epidemics. C. pneumo-
niae and, especially, Legionella seem to be uncom-
mon.
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